Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2014, Article ID 790834, 13 pages
http://dx.doi.org/10.1155/2014/790834
Review Article

Update on Anaplastic Thyroid Carcinoma: Morphological, Molecular, and Genetic Features of the Most Aggressive Thyroid Cancer

1Pathology Unit, IRCCS-Arcispedale Santa Maria Nuova, Viale Risorgimento 80, 42123 Reggio Emilia, Italy
2Laboratory of Translational Research, Research and Statistic Infrastructure, Arcispedale S. Maria Nuova-IRCCS, 42123 Reggio Emilia, Italy

Received 30 May 2014; Accepted 8 July 2014; Published 21 August 2014

Academic Editor: Giovanni Tallini

Copyright © 2014 Moira Ragazzi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [52 citations]

The following is the list of published articles that have cited the current article.

  • Dong Hae Chung, Na Rae Kim, Taeeun Kim, Jungsuk Ahn, Sangho Lee, Young Don Lee, and Hyun Yee Cho, “Malignant Glomus Tumor of the Thyroid Gland Where Is Heretofore an Unreported Organ: a Case Report and Literature Review,” Endocrine Pathology, 2014. View at Publisher · View at Google Scholar
  • Devora Champa, and Antonio Di Cristofano, “Modeling Anaplastic Thyroid Carcinoma in the Mouse,” Hormones and Cancer, vol. 6, no. 1, pp. 37–44, 2014. View at Publisher · View at Google Scholar
  • Christina A von Roemeling, and John A Copland, “Targeting lipid metabolism for the treatment of anaplastic thyroid carcinoma,” Expert Opinion on Therapeutic Targets, pp. 1–8, 2015. View at Publisher · View at Google Scholar
  • Catarina Eloy, Luciana Fereira, Catarina Salgado, Paula Soares, and Manuel Sobrinho-Simões, “Poorly differentiated and undifferentiated thyroid carcinomas,” Turk Patoloji Dergisi, vol. 31, pp. 48–59, 2015. View at Publisher · View at Google Scholar
  • Kristen A. Marten, and Vinay K. Gudena, “Use of Vemurafenib in Anaplastic Thyroid Carcinoma: A Case Report,” Cancer Biology & Therapy, pp. 00–00, 2015. View at Publisher · View at Google Scholar
  • Raktim Biswas, Arindam Mondal, and Jin-Chul Ahn, “Deregulation of EGFR/PI3K and activation of PTEN by photodynamic therapy combined with carboplatin in human anaplastic thyroid cancer cells and xenograft tumors in nude mice,” Journal of Photochemistry and Photobiology B: Biology, vol. 148, pp. 118–127, 2015. View at Publisher · View at Google Scholar
  • John W. Kunstman, C. Christofer Juhlin, Gerald Goh, Taylor C. Brown, Adam Stenman, James M. Healy, Jill C. Rubinstein, Murim Choi, Nimrod Kiss, Carol Nelson-Williams, Shrikant Mane, David L. Rimm, Manju L. Prasad, Anders Hoog, Jan Zedenius, Catharina Larsson, Reju Korah, Richard P. Lifton, and Tobias Carling, “Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing,” Human Molecular Genetics, vol. 24, no. 8, pp. 2318–2329, 2015. View at Publisher · View at Google Scholar
  • Katayoon Kasaian, Sam M. Wiseman, Blair A. Walker, Jacqueline E. Schein, Yongjun Zhao, Martin Hirst, Richard A. Moore, Andrew J. Mungall, Marco A. Marra, and Steven JM Jones, “The genomic and transcriptomic landscape of anaplastic thyroid cancer: implications for therapy,” BMC Cancer, vol. 15, no. 1, 2015. View at Publisher · View at Google Scholar
  • Lindsay Goicochea, and Paul N. Staats, “Anaplastic Thyroid Carcinoma, a Cytologic Perspective,” Pathology Case Reviews, vol. 20, no. 5, pp. 214–217, 2015. View at Publisher · View at Google Scholar
  • James P. Solomon, Fang Wen, and Lily J. Jih, “Anaplastic Transformation of Papillary Thyroid Cancer in the Retroperitoneum,” Case Reports in Pathology, vol. 2015, pp. 1–4, 2015. View at Publisher · View at Google Scholar
  • Carla Visciano, Nella Prevete, Federica Liotti, and Gianni Marone, “Tumor-Associated Mast Cells in Thyroid Cancer,” International Journal of Endocrinology, vol. 2015, pp. 1–8, 2015. View at Publisher · View at Google Scholar
  • Karina Galoian, Shihua Luo, Amir Qureshi, Parthik Patel, Rachel Price, Ashlyn S. Morse, Gor Chailyan, Silva Abrahamyan, and H. T. Temple, “Effect of cytostatic proline rich polypeptide-1 on tumor suppressors of inflammation pathway signaling in chondrosarcoma,” Molecular and Clinical Oncology, vol. 5, no. 5, pp. 618–624, 2016. View at Publisher · View at Google Scholar
  • Hyunsung Kim, Yong Wook Park, Young-Ha Oh, Jongmin Sim, Jae Y. Ro, and Ju Yeon Pyo, “Anaplastic Transformation of Papillary Thyroid Carcinoma Only Seen in Pleural Metastasis: A Case Report with Review of the Literature,” Head and Neck Pathology, 2016. View at Publisher · View at Google Scholar
  • Yiren Hu, Hui Wang, Ende Chen, Zhifeng Xu, Bi Chen, and Guowen Lu, “Candidate microRNAs as biomarkers of thyroid carcinoma: a systematic review, meta-analysis, and experimental validation,” Cancer Medicine, 2016. View at Publisher · View at Google Scholar
  • Giuseppe Palladino, Tiziana Notarangelo, Giuseppe Pannone, Annamaria Piscazzi, Olga Lamacchia, Lorenza Sisinni, Girolamo Spagnoletti, Paolo Toti, Angela Santoro, Giovanni Storto, Pantaleo Bufo, Mauro Cignarelli, Franca Esposito, and Matteo Landriscina, “TRAP1 regulates cell cycle and apoptosis in thyroid carcinoma cells,” Endocrine-Related Cancer, vol. 23, no. 9, pp. 699–709, 2016. View at Publisher · View at Google Scholar
  • Min Ji Jeon, Sung-Min Chun, Deokhoon Kim, Hyemi Kwon, Eun Kyung Jang, Tae Yong Kim, Won Bae Kim, Young Kee Shong, Se Jin Jang, Dong Eun Song, and Won Gu Kim, “ Genomic Alterations of Anaplastic Thyroid Carcinoma Detected by Targeted Massive Parallel Sequencing in a BRAF V600E Mutation-Prevalent Area ,” Thyroid, 2016. View at Publisher · View at Google Scholar
  • Annette M. Lim, Andrew Fellowes, Laird Cameron, Danny Rischin, Graham R. Taylor, Belinda Lee, Rodney J. Hicks, Grant A. McArthur, Christopher Angel, and Benjamin Solomon, “BRAF inhibition in BRAFV600E-positive anaplastic thyroid carcinoma,” JNCCN Journal of the National Comprehensive Cancer Network, vol. 14, no. 3, pp. 249–254, 2016. View at Publisher · View at Google Scholar
  • Gang Liu, Futing Jiang, Jiangping Xie, Yan Zhang, Shihe Wu, and Yuhong Wang, “Zinc finger E-box-binding homeobox 1: Its clinical significance and functional role in human thyroid cancer,” OncoTargets and Therapy, vol. 9, pp. 1303–1310, 2016. View at Publisher · View at Google Scholar
  • Sarika N. Rao, and Mouhammed Amir Habra, “Therapies for Locally Advanced and Metastatic Adrenocortical Carcinoma,” Management of Adrenal Masses in Children and Adults, pp. 257–275, 2016. View at Publisher · View at Google Scholar
  • M. Massaro, S. Riela, C. Baiamonte, J. L. J. Blanco, C. Giordano, P. Lo Meo, S. Milioto, R. Noto, F. Parisi, G. Pizzolanti, and G. Lazzara, “Dual drug-loaded halloysite hybrid-based glycocluster for sustained release of hydrophobic molecules,” RSC Adv., vol. 6, no. 91, pp. 87935–87944, 2016. View at Publisher · View at Google Scholar
  • Mark Benedict, and Jose Costa, “Metastatic Papillary Thyroid Carcinoma with Multifocal Synchronous Transformation to Anaplastic Thyroid Carcinoma,” Case Reports in Pathology, vol. 2016, pp. 1–5, 2016. View at Publisher · View at Google Scholar
  • Clara Ugolini, Fulvio Basolo, Giuliana Salvatore, Francesca Maria Orlandella, and Gennaro Di Maro, “TWIST1/miR-584/TUSC2 pathway induces resistance to apoptosis in thyroid cancer cells,” Oncotarget, vol. 7, no. 43, pp. 70575–70588, 2016. View at Publisher · View at Google Scholar
  • Chiara Anania Maria, Elena Cetti, Daniele Lecis, Katia Todoerti, Alessandro Gulino, Giuseppe Mauro, Tiziana Di Marco, Loredana Cleris, Sonia Pagliardini, Giacomo Manenti, Beatrice Belmonte, Claudio Tripodo, Antonino Neri, and Angela Greco, “Targeting COPZ1 non-oncogene addiction counteracts the viability of thyroid tumor cells,” Cancer Letters, 2017. View at Publisher · View at Google Scholar
  • Naoki Oishi, Tetsuo Kondo, Aya Ebina, Yukiko Sato, Junko Akaishi, Rumi Hino, Noriko Yamamoto, Kunio Mochizuki, Tadao Nakazawa, Hiroshi Yokomichi, Koichi Ito, Yuichi Ishikawa, and Ryohei Katoh, “Molecular alterations of coexisting thyroid papillary carcinoma and anaplastic carcinoma: identification of TERT mutation as an independent risk factor for transformation,” Modern Pathology, 2017. View at Publisher · View at Google Scholar
  • Ruchi Nagpal, Manju Kaushal, and Sawan Kumar, “Cytological diagnosis of an uncommon high grade malignant thyroid tumour: A case report,” Journal of Clinical and Diagnostic Research, vol. 11, no. 7, pp. ED03–ED05, 2017. View at Publisher · View at Google Scholar
  • Karen Zwaenepoel, Julie Jacobs, Astrid De Meulenaere, Karen Silence, Evelien Smits, Vasiliki Siozopoulou, Esther Hauben, Christian Rolfo, Sylvie Rottey, and Patrick Pauwels, “CD70 and PD-L1 in anaplastic thyroid cancer?-?promising targets for immunotherapy,” Histopathology, 2017. View at Publisher · View at Google Scholar
  • Thanyawat Sasanakietkul, Timothy D. Murtha, Mahsa Javid, Reju Korah, and Tobias Carling, “Epigenetic modifications in poorly differentiated and anaplastic thyroid cancer,” Molecular and Cellular Endocrinology, 2017. View at Publisher · View at Google Scholar
  • Casimiro Luca Gigliotti, Benedetta Ferrara, Sergio Occhipinti, Elena Boggio, Giuseppina Barrera, Stefania Pizzimenti, Mirella Giovarelli, Roberto Fantozzi, Annalisa Chiocchetti, Monica Argenziano, Nausicaa Clemente, Francesco Trotta, Caterina Marchiò, Laura Annaratone, Renzo Boldorini, Umberto Dianzani, Roberta Cavalli, and Chiara Dianzani, “ Enhanced cytotoxic effect of camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in vivo on orthotopic xenograft tumors ,” Drug Delivery, vol. 24, no. 1, pp. 670–680, 2017. View at Publisher · View at Google Scholar
  • Sarika N. Rao, Mark Zafereo, Ramona Dadu, Naifa L. Busaidy, Kenneth Hess, Gilbert J. Cote, Michelle D. Williams, William N. William, Vlad Sandulache, Neil Gross, G. Brandon Gunn, Charles Lu, Renata Ferrarotto, Stephen Y. Lai, and Maria E. Cabanillas, “Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma,” Thyroid, 2017. View at Publisher · View at Google Scholar
  • S. Ahmed, M.P. Ghazarian, M.E. Cabanillas, M.E. Zafereo, M.D. Williams, T. Vu, D.F. Schomer, and J.M. Debnam, “Imaging of Anaplastic Thyroid Carcinoma,” American Journal of Neuroradiology, 2017. View at Publisher · View at Google Scholar
  • Martina Tavarelli, Pasqualino Malandrino, Paolo Vigneri, Pierina Richiusa, Adele Maniglia, Maria A. Violi, Giulia Sapuppo, Veronica Vella, Gabriella Dardanoni, Riccardo Vigneri, and Gabriella Pellegriti, “Anaplastic Thyroid Cancer in Sicily: The Role of Environmental Characteristics,” Frontiers in Endocrinology, vol. 8, 2017. View at Publisher · View at Google Scholar
  • O. V. Dolzhansky, E. M. Paltseva, D. N. Khmelkova, F. A. Konovalov, I. V. Kanivets, A. V. Lavrov, D. V. Pyankov, S. A. Korostelev, O. A. Levendyuk, V. M. Pominalnaya, and D. N. Fedorov, “BRAF-positive paucicellular variant of anaplastic carcinoma in the presence of tall cell variant papillary thyroid cancer,” Arkhiv patologii, vol. 79, no. 3, pp. 27, 2017. View at Publisher · View at Google Scholar
  • Antoine Nobile, Julien Ducry, Lucie Vignot, and Massimo Bongiovanni, “Hazardous cross-reaction in a thyroid fine needle aspiration,” Cytopathology, 2018. View at Publisher · View at Google Scholar
  • Shabirhusain Abadin, Paritosh Suman, Jessica Hwang, Anu Thakrar, and Subhash Patel, “First-Line Therapy for Anaplastic Thyroid Cancer: Operation Versus Medical Management,” Difficult Decisions in Endocrine Surgery, pp. 123–139, 2018. View at Publisher · View at Google Scholar
  • Anish Jacob Cherian, and Deepak Abraham, “Anaplastic Thyroid Carcinoma,” Evidence-Based Endocrine Surgery, pp. 151–161, 2018. View at Publisher · View at Google Scholar
  • Audrey Deeken-Draisey, Guang-Yu Yang, Juehua Gao, and Borislav A. Alexie, “Anaplastic thyroid carcinoma: an epidemiologic, histologic, immunohistochemical and molecular single institution study,” Human Pathology, 2018. View at Publisher · View at Google Scholar
  • Cristina Gallo, Valentina Fragliasso, Benedetta Donati, Federica Torricelli, Annalisa Tameni, Simonetta Piana, and Alessia Ciarrocchi, “The bHLH transcription factor DEC1 promotes thyroid cancer aggressiveness by the interplay with NOTCH1,” Cell Death & Disease, vol. 9, no. 9, 2018. View at Publisher · View at Google Scholar
  • Wenshuang Wu, Qian Zhou, Wanjun Zhao, Yanping Gong, Anping Su, Feng Liu, Yang Liu, Zhihui Li, and Jingqiang Zhu, “Ginsenoside Rg3 Inhibition of Thyroid Cancer Metastasis Is Associated with Alternation of Actin Skeleton,” Journal of Medicinal Food, 2018. View at Publisher · View at Google Scholar
  • Chih-Yi Liu, and Shih-Hung Huang, “EBV-associated lymphoepithelioma-like thyroid carcinoma with favorable outcome: case report with cytopathologic and histopathologic study,” Diagnostic Pathology, vol. 13, no. 1, 2018. View at Publisher · View at Google Scholar
  • Haorong Wu, and Tianzhou Zha, “Expression of serum AMPD1 in thyroid carcinoma and its clinical significance,” Experimental and Therapeutic Medicine, vol. 15, no. 4, pp. 3357–3361, 2018. View at Publisher · View at Google Scholar
  • Marra Aghajani, Susannah Graham, Charles McCafferty, Christina Abdel Shaheed, Tara Roberts, Paul DeSouza, Tao Yang, and Navin Niles, “The clinicopathological and prognostic significance of programmed cell death ligand 1 (PD-L1) expression in patients with non-medullary thyroid cancer: a systematic review and meta-analysis,” Thyroid, 2018. View at Publisher · View at Google Scholar
  • Yanling Zhang, Heng Tang, Huaiyuan Hu, and Xiang Yong, “A Rare Primary Tumor of the Thyroid Gland: A New Case of Leiomyoma and Literature Review,” Clinical Medicine Insights: Oncology, vol. 12, pp. 117955491881353, 2018. View at Publisher · View at Google Scholar
  • Shikha Saini, Kiara Tulla, Ajay V. Maker, Kenneth D. Burman, and Bellur S. Prabhakar, “Therapeutic advances in anaplastic thyroid cancer: a current perspective,” Molecular Cancer, vol. 17, no. 1, 2018. View at Publisher · View at Google Scholar
  • Tirtha K Das, and Ross L Cagan, “Non-mammalian models of multiple endocrine neoplasia type 2,” Endocrine-Related Cancer, vol. 25, no. 2, pp. T91–T104, 2018. View at Publisher · View at Google Scholar
  • Quan-Yong Luo, Weijun Wei, and Heather Hardin, “Targeting autophagy in thyroid cancers,” Endocrine-Related Cancer, vol. 26, no. 4, pp. R181–R194, 2018. View at Publisher · View at Google Scholar
  • Ana Sofia Figueiredo, and Patrícia Andrea-Ferreira, “New perspectives regarding anaplastic thyroid carcinoma approach improvement,” Endocrine, Metabolic and Immune Disorders - Drug Targets, vol. 18, no. 6, pp. 555–564, 2018. View at Publisher · View at Google Scholar
  • Joana Simões-Pereira, Ricardo Capitão, Edward Limbert, and Valeriano Leite, “Anaplastic Thyroid Cancer: Clinical Picture of the Last Two Decades at a Single Oncology Referral Centre and Novel Therapeutic Options,” Cancers, vol. 11, no. 8, pp. 1188, 2019. View at Publisher · View at Google Scholar
  • Ana T. Pinto, Marta Pojo, Joana Simões-Pereira, Ruben Roque, Ana Saramago, Lúcia Roque, Carmo Martins, Saudade André, José Cabeçadas, Valeriano Leite, and Branca M. Cavaco, “Establishment and characterization of a new patient-derived anaplastic thyroid cancer cell line (C3948), obtained through fine-needle aspiration cytology,” Endocrine, 2019. View at Publisher · View at Google Scholar
  • Diana P. Sousa, Marta Pojo, Ana T. Pinto, Valeriano Leite, Ana Teresa Serra, and Branca M. Cavaco, “Nobiletin Alone or in Combination with Cisplatin Decreases the Viability of Anaplastic Thyroid Cancer Cell Lines,” Nutrition and Cancer, pp. 1–12, 2019. View at Publisher · View at Google Scholar
  • Francesca Maletta, Jasna Metovic, Marco Volante, and Mauro Papotti, “Poorly Differentiated Carcinoma and Anaplastic Carcinoma of the Thyroid,” Thyroid FNA Cytology, pp. 371–384, 2019. View at Publisher · View at Google Scholar
  • Somboon Keelawat, and Andrey Bychkov, “Anaplastic Thyroid Carcinoma,” Thyroid FNA Cytology, pp. 385–398, 2019. View at Publisher · View at Google Scholar
  • Neha Kaushik, Min-Jung Kim, Nagendra Kumar Kaushik, Jae Kyung Myung, Mi-Young Choi, Jae-Hyeok Kang, Hyuk-Jin Cha, Cha-Soon Kim, Seon-Young Nam, and Su-Jae Lee, “Low dose radiation regulates BRAF-induced thyroid cellular dysfunction and transformation,” Cell Communication and Signaling, vol. 17, no. 1, 2019. View at Publisher · View at Google Scholar